(Q62041405)

English

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

AMPLITUDE-L (English)

0 references

title

A 56-week, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) (English)

0 references

0 references

0 references

3 December 2018

0 references

end time

April 2021